title: The Controlling Cancer Summit, 17-19 May 2016, London, UK.
abstract: The Controlling Cancer Summit, London, UK, 17-19 May 2016 The Controlling Cancer Summit is an intimate informal meeting that annually gathers international academic and clinical researchers to network and debate the current advancements and challenges of oncology research. This year, it focused not only on diagnostic/prognostic biomarkers and genetic influences in cancer but also novel and sometimes unconventional therapeutic interventions. This report will summarize the meeting highlights that contribute to our comprehension of cancer biology and new innovative ways to target this disease.
authors.affiliation: Molecular Oncology, The Breast Cancer Now Research Centre, The Institute of Cancer Research, London, SW3 9JB, UK.
authors.forename: Irina S
authors.initials: IS
authors.lastname: Babina
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001688:Biological Products / Q000494:pharmacology / Q000627:therapeutic use; D004249:DNA Damage; D004260:DNA Repair; D055354:Exosomes / Q000378:metabolism; D006801:Humans; D050997:Nanomedicine / Q000379:methods; D009369:Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents; D001688:Biological Products
keywords: DNA damage; biomarkers; diagnosis; exosomes; nanomedicines; prognosis; therapeutics